Skip to main content

Virtual visit appointments available 7 days a week from 9:00am to 11:00pm. Learn More

COVID-19 Updates

COVID-19 Updates: Get the latest on vaccine information, in-person appointments, virtual visits and more. Learn More


Texas Medical Center

Cancer and Hematology
Phone: 832-824-4223
Fax: 832-825-0872


6701 Fannin, Ste. 1510
Houston, TX 77030

Anil P. George, MD

Assistant Professor, Department of Pediatrics, Section of Hematology/Oncology, Baylor College of Medicine


School Education Degree Year
University of Illinois College of Medicine Fellowship Pediatric Hematology/Oncology 2019
University of Kentucky College of Medicine Residency Pediatrics 2016
American University of Antigua College of Medicine Medical School Doctor of Medicine 2013
University of California, Davis Bachelors Bachelor of Arts 2007


Dr. Anil George began his stem cell transplant fellowship training in 2019. Dr. Anil George completed his pediatric residency training in 2016 and his pediatric hematology/oncology training in 2019. He is board-certified in General Pediatrics by the American Board of Pediatrics.

Dr. George decided to pursue a career in pediatric hematology and oncology because he has a passion for providing personalized and empathic care to children with blood and cancer disorders. He is interested in studying how to integrate technology and combine laboratory discoveries to improve current and future treatment strategies.

Since the outset of his training experiences, Dr. George has had an interest in clinical research. His clinical research included using text-message reminders to improve rates of flu vaccine immunization in children with sickle cell disease and investigating whether propranolol premedication was safe and viable in improving how PET scans are performed in pediatric oncology patients. With an interest in children undergoing bone marrow transplant, Dr. George published a review paper highlighting the complications associated with patients who undergo bone marrow transplantation and cellular immunotherapy treatment to help guide healthcare providers with the diagnosis and management of these complications. Dr. George also published a review paper that provides an overview regarding biomarkers that are currently being used in cancer immunotherapy diagnosis and treatment.

Dr. George is interested in caring for children who are undergoing bone marrow transplantation as part of the treatment for their blood, cancer, immune, and genetic disorders.

Board Certifications
American Board of Pediatrics


Organization Name Role
American Academy of Pediatrics (AAP) Member
American Medical Association (AMA) Member
American Society of Bone Marrow Transplantation (ASBMT) Member
American Society of Clinical Oncology (ASCO) Member
American Society of Hematology (ASH) Member
American Society of Pediatric Hematology/Oncology (ASPHO) Member
Children’s Oncology Group (COG) Member

Research Statement

Dr. Anil George's research interests include investigating the expression of immune checkpoint molecules on immune cells in children and young adult patients with acute leukemia.

The background for this research is that immunotherapy has emerged as a potential treatment option for children and young adults who either do not respond to conventional chemotherapy or suffer relapse related to their disease. Immunotherapy, however, is still in the early phases of development as researchers are investigating which patients will have a favorable response to immunotherapy and are identifying biomarkers that can be used to both predict and monitor a patient's response to treatment. Identifying these markers could also potentially serve as a target for therapy.

Awards & Honors

2022    Clover Award for contributions to patient quality and safety, Texas Children's Hospital



* Texas Children's Hospital physicians' licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician's office and were not verified by Texas Children's Hospital.